Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 18 de 18
Filtrar
1.
Arch Endocrinol Metab ; 62(3): 366-369, 2018 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-29791662

RESUMO

OBJECTIVE: Graves' ophthalmopathy (GO) is an autoimmune disease that leads to ocular proptosis caused by fat accumulation and inflammation, and the main treatment is corticosteroid therapy. Retinoid acid receptor-alpha (RARα) seems to be associated with inflammation and adipocyte differentiation. This study aimed to assess the effect of glucocorticoid treatment on orbital fibroblasts of GO patient treated or not with different glucocorticoid doses. MATERIALS AND METHODS: Orbital fibroblasts collected during orbital decompression of a female patient with moderately severe/severe GO were cultivated and treated with 10 nM and 100 nM dexamethasone (Dex). rRARα gene expression in the treated and untreated cells was then compared. RESULTS: Fibroblast RARα expression was not affected by 100 nM Dex. On the other hand, RARα expression was 24% lower in cells treated with 10 nM Dex (p < 0.05). CONCLUSIONS: Orbital fibroblasts from a GO patient expressed the RARα gene, which was unaffected by higher, but decreased with lower doses of glucocorticoid.


Assuntos
Dexametasona/administração & dosagem , Fibroblastos/química , Expressão Gênica/efeitos dos fármacos , Glucocorticoides/administração & dosagem , Oftalmopatia de Graves/tratamento farmacológico , Órbita/efeitos dos fármacos , Receptor alfa de Ácido Retinoico/genética , Fibroblastos/efeitos dos fármacos , Oftalmopatia de Graves/patologia , Humanos , Órbita/patologia , Receptor alfa de Ácido Retinoico/efeitos dos fármacos , Índice de Gravidade de Doença
2.
Arch. endocrinol. metab. (Online) ; 62(3): 366-369, May-June 2018. graf
Artigo em Inglês | LILACS | ID: biblio-1038490

RESUMO

ABSTRACT Objective: Graves' ophthalmopathy (GO) is an autoimmune disease that leads to ocular proptosis caused by fat accumulation and inflammation, and the main treatment is corticosteroid therapy. Retinoid acid receptor-alpha (RARα) seems to be associated with inflammation and adipocyte differentiation. This study aimed to assess the effect of glucocorticoid treatment on orbital fibroblasts of GO patient treated or not with different glucocorticoid doses. Materials and methods: Orbital fibroblasts collected during orbital decompression of a female patient with moderately severe/severe GO were cultivated and treated with 10 nM and 100 nM dexamethasone (Dex). rRARα gene expression in the treated and untreated cells was then compared. Results: Fibroblast RARα expression was not affected by 100 nM Dex. On the other hand, RARα expression was 24% lower in cells treated with 10 nM Dex (p < 0.05). Conclusions: Orbital fibroblasts from a GO patient expressed the RARα gene, which was unaffected by higher, but decreased with lower doses of glucocorticoid.


Assuntos
Humanos , Órbita/efeitos dos fármacos , Dexametasona/administração & dosagem , Expressão Gênica/efeitos dos fármacos , Oftalmopatia de Graves/tratamento farmacológico , Fibroblastos/química , Glucocorticoides/administração & dosagem , Órbita/patologia , Índice de Gravidade de Doença , Oftalmopatia de Graves/patologia , Fibroblastos/efeitos dos fármacos , Receptor alfa de Ácido Retinoico/efeitos dos fármacos , Receptor alfa de Ácido Retinoico/genética
3.
Age Ageing ; 47(4): 527-536, 2018 07 01.
Artigo em Inglês | MEDLINE | ID: mdl-29415116

RESUMO

BACKGROUND: infectious diseases in older people are associated with higher mortality rates and probiotics have been hypothesised to reduce the occurrence of infection. OBJECTIVES: to assess the effectiveness and safety of probiotics in the occurrence of infections in older adults in comparison to placebo. METHODS: a systematic review and meta-analysis of randomised placebo-controlled trials were conducted on 30 December 2016 using Medline, Embase, CENTRAL, Web of Science and LILACS databases. Efficacy outcomes were: occurrence of infection, quality of life, mortality and mean duration of infection per episode. Safety outcomes were adverse events. Data were analysed using relative risk ratios with 95% confidence intervals. Relative risk ratios were pooled where more than three estimates were available. RESULTS: fifteen articles were included, with a total of 5,916 participants with a mean age of 75.21 years. The effect of probiotics was not significantly different from that reported for placebo on the occurrence of infection, adverse events, mortality or mean duration of infection episodes (relative risk (RR) 0.90, 95% confidence interval (CI) 0.76 to 1.08; RR 1.01, 95% CI 0.91 to 1.12; RR 1.09, 95% CI 0.70 to 1.72; MD -0.35, 95% CI -1.57 to 0.87, respectively). CONCLUSION: the current low-quality evidence does not support the use of probiotics for the reduction in the occurrence of infection in older adults, however, the safety outcomes were similar between probiotics and placebo. Further research is required to confirm these findings.PROSPERO: CRD42014013707.


Assuntos
Envelhecimento , Doenças Transmissíveis/terapia , Controle de Infecções/métodos , Probióticos/uso terapêutico , Fatores Etários , Idoso , Idoso de 80 Anos ou mais , Doenças Transmissíveis/diagnóstico , Doenças Transmissíveis/microbiologia , Doenças Transmissíveis/mortalidade , Feminino , Nível de Saúde , Interações Hospedeiro-Patógeno , Humanos , Masculino , Pessoa de Meia-Idade , Probióticos/efeitos adversos , Fatores de Risco , Resultado do Tratamento
4.
Arch. endocrinol. metab. (Online) ; 60(5): 411-419, Oct. 2016. tab, graf
Artigo em Inglês | LILACS | ID: lil-798181

RESUMO

ABSTRACT We conducted a systematic review and meta-analysis of randomized and non-randomized controlled trials that compared pure endoscopic with microscopic transsphenoidal surgery (TSS) in the resection of pituitary tumors. Embase, PubMed, Lilacs, and Central Cochrane were used as our data sources. The outcomes were total tumor resection, achievement of biochemical control of functioning adenomas, hospital stay and surgery complications. The randomized trials were analyzed using the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) approach. Two randomized and three prospective controlled non-randomized studies were included. Two studies, including 68 patients, evaluated total tumor resection and the meta-analysis did not show differences between the groups [RR: 1.45 (95% CI: 0.87, 2.44)]. Three studies involving 65 patients analyzed the achievement of biochemical control and no statistical difference was found [RR: 0.94 (95% CI: 0.7, 1.26)]. All five studies compared the frequency of postoperative complications between intervention and control group and meta-analysis favored for a low rate of postoperative complications in the endoscopic TSS group [(RR: 0.37 (95% CI: 0.16, 0.83)]. Due to the low evidence level and low number of observations, the results of our meta-analysis should not be viewed as a final proof of inferiority or superiority of one approach in relation to the other. More data including higher numbers of observations are needed.

5.
Arch Endocrinol Metab ; 60(5): 411-419, 2016 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-27598981

RESUMO

We conducted a systematic review and meta-analysis of randomized and non-randomized controlled trials that compared pure endoscopic with microscopic transsphenoidal surgery (TSS) in the resection of pituitary tumors. Embase, PubMed, Lilacs, and Central Cochrane were used as our data sources. The outcomes were total tumor resection, achievement of biochemical control of functioning adenomas, hospital stay and surgery complications. The randomized trials were analyzed using the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) approach. Two randomized and three prospective controlled non-randomized studies were included. Two studies, including 68 patients, evaluated total tumor resection and the meta-analysis did not show differences between the groups [RR: 1.45 (95% CI: 0.87, 2.44)]. Three studies involving 65 patients analyzed the achievement of biochemical control and no statistical difference was found [RR: 0.94 (95% CI: 0.7, 1.26)]. All five studies compared the frequency of postoperative complications between intervention and control group and meta-analysis favored for a low rate of postoperative complications in the endoscopic TSS group [(RR: 0.37 (95% CI: 0.16, 0.83)]. Due to the low evidence level and low number of observations, the results of our meta-analysis should not be viewed as a final proof of inferiority or superiority of one approach in relation to the other. More data including higher numbers of observations are needed.

6.
J Gastroenterol Hepatol ; 31(1): 229-34, 2016 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-26212461

RESUMO

BACKGROUND AND AIM: Osteoporosis is well recognized as a cirrhosis complication; however, most studies assessing this condition included only patients on liver transplantation lists with an elevated rate of bone diseases. While general population studies show that handgrip strength is clearly associated with bone mineral density, until now this tool has not been applied to patients with cirrhosis in relation to their bone condition. This study aimed to evaluate whether handgrip strength, bone, and liver tests may be useful as predictors of bone disease in outpatients with cirrhosis. METHODS: One hundred twenty-nine subjects were included (77 men and 52 women). Dual-energy X-ray absorptiometry was applied to evaluate lumbar-spine and femoral-neck T scores. Osteoporosis/osteopenia rates were 26.3%/35.6% in the lumbar spine and 6.9%/41.8% in the femoral neck, respectively. Model selections were based on backward procedures to find the best predictors of low T scores. RESULTS: For lumbar spine, only low handgrip strength and high parathyroid hormone levels were clearly related to low T scores. For femoral neck, only age was associated with low T scores. CONCLUSIONS: Handgrip strength may serve as an effective predictor of low lumbar spine T score among outpatients with cirrhosis. As cirrhosis affects the lumbar spine more than the femoral neck, these results suggest that handgrip strength should be tested in all patients with cirrhosis as a first indicator of bone health.


Assuntos
Densidade Óssea , Força da Mão/fisiologia , Cirrose Hepática/complicações , Osteoporose/diagnóstico , Osteoporose/etiologia , Pacientes Ambulatoriais , Absorciometria de Fóton , Feminino , Colo do Fêmur , Humanos , Vértebras Lombares , Masculino , Pessoa de Meia-Idade , Osteoporose/fisiopatologia , Valor Preditivo dos Testes
7.
J Diabetes Complications ; 30(2): 357-67, 2016 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-26684169

RESUMO

BACKGROUND: The adipocytokines leptin and adiponectin have been variously associated with diabetic microvascular complications. No comprehensive clinical data exist examining the association between adipocytokines and the presence of these complications. METHODS: This is a systematic review of cross-sectional studies comparing circulating adipocytokines in patients with type 2 diabetes mellitus (T2DM), with and without microvascular complications. Studies were retrieved from MEDLINE, EMBASE, Scopus and Cochrane databases. Study quality was evaluated using a modified Newcastle-Ottawa Scale. Meta-analysis was performed using an inverse-variance model, providing standardised mean differences (SMD) and 95% confidence intervals (CI). Heterogeneity was determined by I(2) statistic. RESULTS: Amongst 554 identified studies, 28 were included in the review. Study quality range was 3.5-9 (maximum 11). Higher leptin levels were associated with microalbuminuria (SMD=0.41; 95% CI=0.14-0.67; n=901; p=0.0003), macroalbuminuria (SMD=0.68; 95% CI=0.30-1.06; n=406; p=0.0004), and neuropathy (SMD=0.26; 95% CI=0.07-0.44; n=609; p=0.008). Higher adiponectin levels were associated with microalbuminuria (SMD=0.55; 95% CI=0.29-0.81, n=274; p<0.001), macroalbuminuria (SMD=1.37; 95% CI=0.78-1.97, n=246; p<0.00001), neuropathy (SMD=0.25; 95% CI=0.14-0.36; n=1516; p<0.00001), and retinopathy (SMD=0.38; 95% CI=0.25-0.51; n=1306; p<0.00001). Meta-regression suggested no influence of body mass index and duration of diabetes on effect size, and a weak trend in terms of age on effect size. DISCUSSION: Our meta-analysis suggests leptin and adiponectin levels are higher in T2DM patients with microvascular complications. Studies were limited by cross-sectional design. Large prospective analyses are required to validate these findings.


Assuntos
Adipocinas/sangue , Diabetes Mellitus Tipo 2/sangue , Diabetes Mellitus Tipo 2/complicações , Angiopatias Diabéticas/sangue , Adiponectina/sangue , Idoso , Estudos Transversais , Diabetes Mellitus Tipo 2/epidemiologia , Angiopatias Diabéticas/epidemiologia , Feminino , Humanos , Leptina/sangue , Masculino , Pessoa de Meia-Idade
8.
Arch Endocrinol Metab ; 59(3): 273-6, 2015 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-26154098

RESUMO

Graves' ophthalmopathy (GO) is one of the most severe clinical manifestations of Graves' disease (GD), and its treatment might involve high-dose glucocorticoid therapy. The higher incidence of GO among females, and the reported association between polymorphisms of estrogen receptor (ER) and GD susceptibility have led us to question the role of estrogen and its receptor in GO pathogenesis. We, thus, assessed estrogen receptor-alpha (ERA) gene expression in cultures of orbital fibroblasts from a patient with GO before (controls) and after treatment with 10 nM and 100 nM dexamethasone (DEX). Orbital fibroblasts showed ERA gene expression. In the cells treated with 10 nM and 100 nM DEX, ERA gene expression was, respectively, 85% higher and 74% lower, than in the control group. We concluded that ERA gene expression is found in the orbital fibroblasts of patient with GO, which may be affected by glucocorticoids in a dose-related manner. Arch Endocrinol Metab. 2015;59(3):273-6.


Assuntos
Receptor alfa de Estrogênio/genética , Fibroblastos/metabolismo , Expressão Gênica , Oftalmopatia de Graves/genética , Células Cultivadas , Dexametasona/uso terapêutico , Receptor alfa de Estrogênio/metabolismo , Feminino , Fibroblastos/efeitos dos fármacos , Expressão Gênica/efeitos dos fármacos , Glucocorticoides/uso terapêutico , Oftalmopatia de Graves/tratamento farmacológico , Humanos , Reação em Cadeia da Polimerase em Tempo Real , Resultado do Tratamento
9.
Arq. bras. neurocir ; 34(2): 139-143, jun. 2015. ilus
Artigo em Inglês | LILACS | ID: biblio-1787

RESUMO

Pituitary tumors are responsible for 7 to 17% of all intracranial lesions. Over the past decade, advances in endoscopic microsurgical techniques have resulted in an increasingly aggressive endonasal approach to tumors of the midline skull base. We present our series emphasizing technical nuances of endoscopic endonasal transsphenoidal approach to treat pituitary adenomas.


Tumores hipofisários são responsáveis por 7 a 17% de todas as lesões intracranianas. Durante a última década, avanços nas técnicas microcirúrgicas endoscópicas resultaram no aumento de acessos endonasais agressivos para tumores de base de crânio de linha média. Apresentamos nossa série de casos, com ênfase nos detalhes técnicos do acesso endoscópico endonasal transesfenoidal para o tratamento de tumores da hipófise.


Assuntos
Humanos , Neoplasias Hipofisárias/cirurgia , Adenoma/cirurgia , Neuroendoscopia/métodos
10.
Arch. endocrinol. metab. (Online) ; 59(3): 273-276, 06/2015. graf
Artigo em Inglês | LILACS | ID: lil-751322

RESUMO

Graves’ ophthalmopathy (GO) is one of the most severe clinical manifestations of Graves’ disease (GD), and its treatment might involve high-dose glucocorticoid therapy. The higher incidence of GO among females, and the reported association between polymorphisms of estrogen receptor (ER) and GD susceptibility have led us to question the role of estrogen and its receptor in GO pathogenesis. We, thus, assessed estrogen receptor-alpha (ERA) gene expression in cultures of orbital fibroblasts from a patient with GO before (controls) and after treatment with 10 nM and 100 nM dexamethasone (DEX). Orbital fibroblasts showed ERA gene expression. In the cells treated with 10 nM and 100 nM DEX, ERA gene expression was, respectively, 85% higher and 74% lower, than in the control group. We concluded that ERA gene expression is found in the orbital fibroblasts of patient with GO, which may be affected by glucocorticoids in a dose-related manner. Arch Endocrinol Metab. 2015;59(3):273-6.


Assuntos
Humanos , Adenocarcinoma/patologia , Esôfago de Barrett/patologia , Carcinoma in Situ/patologia , Neoplasias Esofágicas/patologia , Junção Esofagogástrica/patologia , Mucosa/patologia
13.
Arq Bras Endocrinol Metabol ; 57(8): 612-6, 2013 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-24343629

RESUMO

OBJECTIVE: To determine the frequency of colon cancer, primary hyperparathyroidism, thyroid tumor, and skin cancer in all acromegalic patients in follow-up at the Clinics Hospital - Botucatu Medical School, from 2005 to 2011. SUBJECTS AND METHODS: These patients were evaluated retrospectively for colon cancer, primary hyperparathyroidism, dermatological, and thyroid tumors. RESULTS: Of 29 patients included at the beginning of the study, two were excluded. Among 19 patients submitted to colonoscopy, one presented colon adenocarcinoma (5%). Thyroid nodules were present in 63% of patients, and papilliferous carcinoma was confirmed in two patients (7,7%). Four patients were confirmed as having primary hyperparathyroidism (15%). The most common dermatologic lesions were thickened skin (100%), acrochordons (64%), epidermal cysts (50%), and pseudo-acanthosis nigricans (50%). Only one patient presented basal cell carcinoma. CONCLUSION: Although a small number of acromegalic patients was studied, our findings confirm the high frequency of thyroid neoplasias and primary hyperparathyroidism in this group of patients.


Assuntos
Acromegalia/complicações , Adenocarcinoma/epidemiologia , Neoplasias do Colo/epidemiologia , Hiperparatireoidismo Primário/epidemiologia , Neoplasias Cutâneas/epidemiologia , Nódulo da Glândula Tireoide/epidemiologia , Acantose Nigricans/diagnóstico , Acromegalia/sangue , Adenocarcinoma/diagnóstico , Adulto , Idoso , Neoplasias do Colo/diagnóstico , Feminino , Humanos , Hiperparatireoidismo Primário/diagnóstico , Fator de Crescimento Insulin-Like I/análise , Masculino , Pessoa de Meia-Idade , Estudos Retrospectivos , Neoplasias Cutâneas/diagnóstico , Nódulo da Glândula Tireoide/diagnóstico
14.
Arq. bras. endocrinol. metab ; 57(8): 612-616, Nov. 2013. tab
Artigo em Inglês | LILACS | ID: lil-696900

RESUMO

OBJECTIVE: To determine the frequency of colon cancer, primary hyperparathyroidism, thyroid tumor, and skin cancer in all acromegalic patients in follow-up at the Clinics Hospital - Botucatu Medical School, from 2005 to 2011. SUBJECTS AND METHODS: These patients were evaluated retrospectively for colon cancer, primary hyperparathyroidism, dermatological, and thyroid tumors. RESULTS: Of 29 patients included at the beginning of the study, two were excluded. Among 19 patients submitted to colonoscopy, one presented colon adenocarcinoma (5%). Thyroid nodules were present in 63% of patients, and papilliferous carcinoma was confirmed in two patients (7,7%). Four patients were confirmed as having primary hyperparathyroidism (15%). The most common dermatologic lesions were thickened skin (100%), acrochordons (64%), epidermal cysts (50%), and pseudo-acanthosis nigricans (50%). Only one patient presented basal cell carcinoma. CONCLUSION: Although a small number of acromegalic patients was studied, our findings confirm the high frequency of thyroid neoplasias and primary hyperparathyroidism in this group of patients.


OBJETIVO: Determinar a frequência de câncer de cólon, hiperparatireoidismo primário, tumores de tireoide e pele em todos os acromegálicos em seguimento no Hospital de Clínicas da Faculdade de Medicina de Botucatu de 2005 a 2011. SUJEITOS E MÉTODOS: Esses pacientes foram avaliados retrospectivamente quanto a presença de câncer de cólon, hiperparatiroidismo primário, tumores da tiroide e pele. RESULTADOS: Dos 29 pacientes incluídos no início do estudo, dois foram excluídos. Dentre os 19 pacientes submetidos à colonoscopia, um apresentou adenocarcinoma de cólon (5%). Nódulos de tireoide estiveram presentes em 65% dos pacientes e carcinoma papilífero, em dois deles (7,7%). Quatro pacientes apresentaram hiperparatireoidismo primário (15%). A maioria das lesões de pele foram: espessamento (100%), acrochordons (64%), cistos epidérmicos (50%), pseudoacantose nigricans (50%) e apenas um paciente apresentou carcinoma basocelular. CONCLUSÃO: O tamanho da amostra é pequeno, mas nossos achados confirmam a alta frequência da neoplasia da tireoide e hiperparatireroidismo neste grupo de pacientes.


Assuntos
Adulto , Idoso , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Acromegalia/complicações , Adenocarcinoma/epidemiologia , Neoplasias do Colo/epidemiologia , Hiperparatireoidismo Primário/epidemiologia , Neoplasias Cutâneas/epidemiologia , Nódulo da Glândula Tireoide/epidemiologia , Acantose Nigricans/diagnóstico , Acromegalia/sangue , Adenocarcinoma/diagnóstico , Neoplasias do Colo/diagnóstico , Hiperparatireoidismo Primário/diagnóstico , Fator de Crescimento Insulin-Like I/análise , Estudos Retrospectivos , Neoplasias Cutâneas/diagnóstico , Nódulo da Glândula Tireoide/diagnóstico
15.
An Bras Dermatol ; 87(1): 166-8, 2012.
Artigo em Inglês | MEDLINE | ID: mdl-22481676

RESUMO

Acromegaly is a chronic, insidious and rare disease, caused by hyper secretion of the growth hormone, which metabolic and trophic effects commonly result in cutaneous manifestations, sometimes preceding other clinical symptoms. The authors have assessed 15 patients with acromegaly and found dermatologic lesions in all of them, mainly skin thickening, acrochordons, epidermoid cysts, pseudoacanthosis nigricans, seborrheic keratosis, melanocytic naevi and lentiginous spots.


Assuntos
Acromegalia/epidemiologia , Dermatopatias/epidemiologia , Acromegalia/complicações , Adulto , Idoso , Brasil/epidemiologia , Estudos Transversais , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Prevalência , Dermatopatias/etiologia
17.
Arq. bras. endocrinol. metab ; 52(9): 1501-1504, Dec. 2008.
Artigo em Inglês | LILACS | ID: lil-504557

RESUMO

Craniopharyngiomas and germ cell tumors (GCT) may affect the pituitary-hypothalamic region during childhood. Although different in origin, their clinical and radiological features may be similar. In this article we present a 5-year-old girl with clinical and radiological findings (computer tomography calcification) that were initially considered as craniopharyngioma. However clinical outcome, blood and cerebral spinal fluid tumoral markers, and results from anatomopathology and immunohistochemistry disclosed a mixed GCT. This case report highlights that some clinical features and radiological findings of pituitary-hypothalamic tumors may be misdiagnosed as craniopharyngioma mainly when there is a mature teratoma with cartilaginous tissue differentiation.


Craniofaringiomas e tumores mistos de células germinativas (TCG) podem acometer a região hipotálamo-hipofisária durante a infância. Embora tenham diferentes origens, as manifestações clínicas e achados radiológicos podem ser semelhantes. Nosso objetivo é relatar o caso de uma paciente de 5 anos de idade, cujas manifestações clínicas e achados radiológicos (presença de calcificações à tomografia computadorizada [TC]) foram inicialmente considerados como provável craniofaringioma. No entanto, a piora clínica progressiva, marcadores tumorais séricos e liquóricos elevados, assim como os resultados do estudo anatomopatológico e imunoistoquímico revelaram tratar-se de TCG. Este caso enfatiza que alguns achados clínicos e radiológicos de tumores da região hipotálamo-hipofisária podem ser erroneamente diagnosticados como craniofaringiomas, principalmente se houver presença de teratoma maduro com diferenciação em tecido cartilaginoso.


Assuntos
Pré-Escolar , Feminino , Humanos , Craniofaringioma/patologia , Neoplasias Hipotalâmicas/patologia , Neoplasias Embrionárias de Células Germinativas/patologia , Neoplasias Hipofisárias/patologia , Craniofaringioma , Craniofaringioma/cirurgia , Diagnóstico Diferencial , Neoplasias Hipotalâmicas , Neoplasias Hipotalâmicas/cirurgia , Neoplasias Embrionárias de Células Germinativas , Neoplasias Embrionárias de Células Germinativas/cirurgia , Neoplasias Hipofisárias , Neoplasias Hipofisárias/cirurgia , Teratoma/patologia , Teratoma , Teratoma/cirurgia
18.
Arq Bras Endocrinol Metabol ; 52(9): 1501-4, 2008 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-19197460

RESUMO

Craniopharyngiomas and germ cell tumors (GCT) may affect the pituitary-hypothalamic region during childhood. Although different in origin, their clinical and radiological features may be similar. In this article we present a 5-year-old girl with clinical and radiological findings (computer tomography calcification) that were initially considered as craniopharyngioma. However clinical outcome, blood and cerebral spinal fluid tumoral markers, and results from anatomopathology and immunohistochemistry disclosed a mixed GCT. This case report highlights that some clinical features and radiological findings of pituitary-hypothalamic tumors may be misdiagnosed as craniopharyngioma mainly when there is a mature teratoma with cartilaginous tissue differentiation.


Assuntos
Craniofaringioma/patologia , Neoplasias Hipotalâmicas/patologia , Neoplasias Embrionárias de Células Germinativas/patologia , Neoplasias Hipofisárias/patologia , Pré-Escolar , Craniofaringioma/diagnóstico por imagem , Craniofaringioma/cirurgia , Diagnóstico Diferencial , Feminino , Humanos , Neoplasias Hipotalâmicas/diagnóstico por imagem , Neoplasias Hipotalâmicas/cirurgia , Neoplasias Embrionárias de Células Germinativas/diagnóstico por imagem , Neoplasias Embrionárias de Células Germinativas/cirurgia , Neoplasias Hipofisárias/diagnóstico por imagem , Neoplasias Hipofisárias/cirurgia , Radiografia , Teratoma/diagnóstico por imagem , Teratoma/patologia , Teratoma/cirurgia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...